Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ENVX
ENVX logo

ENVX Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
7.320
Open
7.220
VWAP
7.22
Vol
968.80K
Mkt Cap
1.58B
Low
7.010
Amount
6.99M
EV/EBITDA(TTM)
--
Total Shares
218.15M
EV
1.46B
EV/OCF(TTM)
--
P/S(TTM)
41.11
Enovix Corporation is a high-performance battery company. The Company is focused on designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, batteries, including silicon-anode architectures, for smartphones, smart eyewear, defense, industrial and emerging edge artificial intelligence (AI) applications. Its silicon-anode battery architecture enables energy density and performance relative to conventional battery cells, particularly in space-constrained devices. It focuses on developing a battery architecture that allows the use of active silicon and no graphite in the battery's anode, which is the negative electrode that stores lithium ions when a battery is charged. Its AI-1 battery platform is architected as a unified silicon-anode platform designed to address the high-performance consumer electronics and defense applications. The AI-1 platform is designed to support AI-enabled smartphones and smart eyewear, as well as other edge-AI devices.
Show More

Events Timeline

(ET)
2026-05-14
09:00:00
U.S. Futures Rise as Market Optimism Rebounds
select
2026-05-14
08:50:00
Enovix Shares Drop 11% to $6.47
select
2026-05-13 (ET)
2026-05-13
19:00:00
Alphabet and Nvidia Share Prices Hit Record Highs
select
2026-05-13
16:40:00
Enovix Reports Q1 Revenue of $7.6M
select

News

seekingalpha
9.5
05-14seekingalpha
Enovix Q1 2026 Earnings Call Insights
  • Commercialization Progress: Enovix reported Q1 2026 revenue of $7.6 million, despite facing a non-GAAP operating loss of $28.8 million, indicating initial progress in smart eyewear battery production, yet the overall commercialization timeline remains under pressure to meet market demands.
  • Pipeline Expansion: The company's product pipeline in Korea now exceeds $130 million, primarily driven by rapidly growing drone applications, highlighting its market potential in high-demand sectors, although production capacity bottlenecks must be addressed to achieve expected growth.
  • Financial Outlook: Management expects Q2 2026 revenue to range between $8 million and $9 million, reflecting continued growth in defense and industrial shipments, but also anticipates a non-GAAP net loss between $29 million and $32 million, indicating ongoing profitability challenges.
  • Executive Changes: The appointment of Steve Bakos as Senior Vice President of Worldwide Sales, who brings over 35 years of semiconductor sales experience, is expected to drive sales growth, but attention must be paid to his adaptability to the company's strategic direction.
stocktwits
9.5
05-13stocktwits
Enovix Provides Q2 Revenue Guidance Amid Smartphone Delays
  • Earnings Performance: Enovix reported Q1 2026 revenue of $7.6 million, a 49% increase from $5.1 million year-over-year, driven by higher shipments in defense and industrial markets, although the adjusted net loss per share was $0.14, slightly above last year's $0.13.
  • Q2 Guidance: The company provided guidance for Q2 revenue between $8.0 million and $9.0 million, aligning with the expected $8.57 million, while the adjusted net loss per share is projected to be between $0.13 and $0.17, lower than Wall Street's expectation of $0.20.
  • Smartphone Priority: Despite delays in the smartphone battery qualification process, CEO Talluri emphasized that smartphones remain the company's top priority, having reached an agreement with its lead customer on a new testing framework to expedite commercial production.
  • Market Reaction: Although shares fell 12% after hours on Wednesday, retail sentiment on Stocktwits shifted from 'bullish' to 'extremely bullish', indicating recognition of the company's progress across multiple industries, despite disappointment over smartphone testing delays.
seekingalpha
9.5
05-13seekingalpha
Enovix Q1 Results Beat Expectations but Shares Drop
  • Financial Performance: Enovix reported Q1 revenue of $7.6 million, a 49% year-over-year increase that exceeded expectations, yet the net loss widened to $38.3 million, highlighting ongoing cash burn and profitability challenges.
  • Investment and Losses: Although the adjusted loss per share was $0.14, beating the $0.16 estimate, the company faced a negative free cash flow of $36.3 million, reflecting the ongoing need for investment in scaling manufacturing operations.
  • Commercialization Progress: Management emphasized progress in qualifying smartphone batteries, a critical milestone for unlocking large-scale revenue, although the qualification process has taken longer than anticipated, indicating strategic focus in the consumer electronics market.
  • Market Expansion Potential: Enovix is diversifying into new markets such as smart eyewear, drones, and defense systems, with plans to produce 50,000 smart eyewear batteries by 2026 and a product pipeline exceeding $130 million, showcasing significant growth potential through diversification.
seekingalpha
9.5
05-13seekingalpha
Enovix Q1 Earnings Beat Expectations with Strong Revenue Growth
  • Earnings Highlights: Enovix reported a Q1 non-GAAP EPS of -$0.14, beating expectations by $0.02, indicating efforts towards improving profitability despite remaining in the red.
  • Revenue Growth: The company achieved $7.6 million in revenue for Q1, a 49% year-over-year increase that surpassed market expectations by $650,000, showcasing strong performance in market demand and product sales.
  • Cash Position: At the end of the quarter, cash, cash equivalents, and marketable securities totaled approximately $582.7 million, providing ample liquidity to support qualification completion and commercialization scale-up, thereby boosting investor confidence.
  • Future Guidance: Enovix projects Q2 revenue guidance of $8.0 to $9.0 million, although it anticipates a non-GAAP operating loss of $29.0 to $32.0 million, reflecting the challenges and opportunities faced during its expansion efforts.
seekingalpha
9.5
05-12seekingalpha
Enovix Q1 Earnings Announcement Scheduled
  • Earnings Release Date: Enovix (ENVX) is set to announce its Q1 earnings on May 13th after market close, with a consensus EPS estimate of -$0.16, reflecting a 6.7% year-over-year decline, which may dampen investor sentiment.
  • Revenue Growth Expectations: The anticipated revenue for Q1 is $6.95 million, representing a 36.3% year-over-year increase; however, the company must demonstrate sustained revenue growth to improve its overall financial health.
  • Historical Performance Review: Over the past two years, Enovix has beaten EPS estimates 88% of the time and revenue estimates 100% of the time, indicating a degree of stability in financial performance, but the ability to maintain this trend going forward remains uncertain.
  • Expectation Revisions: In the last three months, EPS estimates have seen two upward revisions and three downward revisions, while revenue estimates have experienced two upward and four downward revisions, suggesting a wavering market confidence in Enovix's future performance, which could impact stock price.
NASDAQ.COM
8.0
04-06NASDAQ.COM
Surge in Options Trading Volume for Enovix and Clover Health
  • Enovix Options Volume: Enovix Corp saw options trading volume of 47,349 contracts, equivalent to approximately 4.7 million shares, representing about 85% of its average daily trading volume of 5.6 million shares over the past month, indicating heightened market interest in its future performance.
  • High-Frequency Trading: Notably, the $7 strike call option expiring on October 16, 2026, has seen 11,736 contracts traded today, representing around 1.2 million underlying shares, suggesting increased investor expectations for Enovix's stock price appreciation.
  • Clover Options Activity: Clover Health Investments Corp recorded options trading volume of 45,122 contracts, approximately 4.5 million shares, which accounts for about 80% of its average daily trading volume of 5.6 million shares over the past month, reflecting active market interest in its stock.
  • Clover High-Frequency Trading: The $2 strike call option expiring on April 10, 2026, has seen 13,076 contracts traded today, representing about 1.3 million underlying shares, indicating optimistic sentiment among investors regarding Clover's future performance.
Wall Street analysts forecast ENVX stock price to rise
9 Analyst Rating
Wall Street analysts forecast ENVX stock price to rise
7 Buy
2 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
10.00
Averages
19.00
High
25.00
Current: 0.000
sliders
Low
10.00
Averages
19.00
High
25.00
BofA
Ruplu Bhattacharya
Neutral
maintain
$7 -> $8
AI Analysis
2026-05-14
Reason
BofA
Ruplu Bhattacharya
Price Target
$7 -> $8
AI Analysis
2026-05-14
maintain
Neutral
Reason
BofA analyst Ruplu Bhattacharya raised the firm's price target on Enovix to $8 from $7 and keeps a Neutral rating on the shares after the company reported a fiscal Q1 beat. The firm is applying a higher multiple as it sees a second smartphone customer also agreeing to an alternate testing methodology as "an incremental positive for ultimate revenue generation from smartphones," the analyst tells investors.
Oppenheimer
Colin Rusch
Outperform
maintain
$24 -> $21
2026-05-14
Reason
Oppenheimer
Colin Rusch
Price Target
$24 -> $21
2026-05-14
maintain
Outperform
Reason
Oppenheimer analyst Colin Rusch lowered the firm's price target on Enovix to $21 from $24 and keeps an Outperform rating on the shares. The firm notes the company delivered solid Q1 results and Q2 guidance as it continues to pivot toward drone and military opportunities. While Enovix is making progress on delivering a compelling product for consumer electronics applications and seeing strong interest in drone and defense applications, Oppenheimer says that it's clear the revenue ramp for the company will be slower than it previously anticipated. The firm is pushing out revenue inflection by about five quarters.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ENVX
Unlock Now

Valuation Metrics

The current forward P/E ratio for Enovix Corp (ENVX.O) is 0.00, compared to its 5-year average forward P/E of -14.53. For a more detailed relative valuation and DCF analysis to assess Enovix Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-14.53
Current PE
0.00
Overvalued PE
-4.44
Undervalued PE
-24.63

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-7.69
Current EV/EBITDA
136.57
Overvalued EV/EBITDA
40.27
Undervalued EV/EBITDA
-55.64

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
258.25
Current PS
15.99
Overvalued PS
521.96
Undervalued PS
-5.46

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

Day trading picks
Intellectia · 115 candidates
Price: $5.00 - $100.00Relative Vol: >= 2List Exchange: XNYS, XNAS, XASEMin5 Price Change Pct: $0.50 - $5.00Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
RGTI logo
RGTI
Rigetti Computing Inc
6.58B
RDW logo
RDW
Redwire Corp
2.06B
LUNR logo
LUNR
Intuitive Machines Inc
5.98B
DOW logo
DOW
Dow Inc
25.62B
AXTI logo
AXTI
AXT Inc
4.59B
SBET logo
SBET
Sharplink Inc
1.58B
what is a good stock to buy under $10
Intellectia · 26 candidates
Market Cap: >= 1000.00MPrice: <= $10.00Weekly Average Turnover: >= 2,000,000Pe Ttm: <= 15Annual Revenue Yoy Growth: >= 20.0%
Ticker
Name
Market Cap$
top bottom
IBRX logo
IBRX
Immunitybio Inc
6.82B
RIG logo
RIG
Transocean Ltd
5.10B
DNN logo
DNN
Denison Mines Corp
3.36B
PTEN logo
PTEN
Patterson-UTI Energy Inc
2.79B
RXRX logo
RXRX
Recursion Pharmaceuticals Inc
2.40B
GENI logo
GENI
Genius Sports Ltd
2.32B
good stock picks under $10
Intellectia · 10 candidates
Market Cap: >= 1.50BPrice: <= $10.00Weekly Average Turnover: >= 3,000,000Pe Ttm: <= 12Annual Revenue Yoy Growth: >= 20.0%
Ticker
Name
Market Cap$
top bottom
IBRX logo
IBRX
Immunitybio Inc
6.82B
RIG logo
RIG
Transocean Ltd
5.10B
DNN logo
DNN
Denison Mines Corp
3.36B
PTEN logo
PTEN
Patterson-UTI Energy Inc
2.79B
RXRX logo
RXRX
Recursion Pharmaceuticals Inc
2.40B
GENI logo
GENI
Genius Sports Ltd
2.32B

Whales Holding ENVX

E
Electron Capital Partners, LLC
Holding
ENVX
+16.21%
3M Return
C
Centerbook Partners LP
Holding
ENVX
+9.95%
3M Return
G
Granahan Investment Management, LLC
Holding
ENVX
+4.12%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Enovix Corp (ENVX) stock price today?

The current price of ENVX is 7.315 USD — it has increased 0.9

What is Enovix Corp (ENVX)'s business?

Enovix Corporation is a high-performance battery company. The Company is focused on designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, batteries, including silicon-anode architectures, for smartphones, smart eyewear, defense, industrial and emerging edge artificial intelligence (AI) applications. Its silicon-anode battery architecture enables energy density and performance relative to conventional battery cells, particularly in space-constrained devices. It focuses on developing a battery architecture that allows the use of active silicon and no graphite in the battery's anode, which is the negative electrode that stores lithium ions when a battery is charged. Its AI-1 battery platform is architected as a unified silicon-anode platform designed to address the high-performance consumer electronics and defense applications. The AI-1 platform is designed to support AI-enabled smartphones and smart eyewear, as well as other edge-AI devices.

What is the price predicton of ENVX Stock?

Wall Street analysts forecast ENVX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENVX is19.00 USD with a low forecast of 10.00 USD and a high forecast of 25.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Enovix Corp (ENVX)'s revenue for the last quarter?

Enovix Corp revenue for the last quarter amounts to 7.60M USD, increased 49.08

What is Enovix Corp (ENVX)'s earnings per share (EPS) for the last quarter?

Enovix Corp. EPS for the last quarter amounts to -0.18 USD, increased 50.00

How many employees does Enovix Corp (ENVX). have?

Enovix Corp (ENVX) has 664 emplpoyees as of May 28 2026.

What is Enovix Corp (ENVX) market cap?

Today ENVX has the market capitalization of 1.58B USD.